BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND TP53, TRP53, 7157, ENSG00000141510, P04637, LFS1, P53 AND Treatment
2179 results:

  • 1. Principles in the Management of Glioblastoma.
    Roda D; Veiga P; Melo JB; Carreira IM; Ribeiro IP
    Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674436
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A multi-omics analysis-based model to predict the prognosis of low-grade gliomas.
    Du Z; Jiang Y; Yang Y; Kang X; Yan J; Liu B; Yang M
    Sci Rep; 2024 Apr; 14(1):9427. PubMed ID: 38658591
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. DKK3 Expression in Glioblastoma: Correlations with Biomolecular Markers.
    Caffo M; Casili G; Caruso G; Barresi V; Campolo M; Paterniti I; Minutoli L; Ius T; Esposito E
    Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612910
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Roles and interactions of tumor microenvironment components in medulloblastoma with implications for novel therapeutics.
    Yang H; Li M; Deng Y; Wen H; Luo M; Zhang W
    Genes Chromosomes Cancer; 2024 Apr; 63(4):e23233. PubMed ID: 38607297
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Focused ultrasound-mediated blood-brain barrier opening is safe and feasible with moderately hypofractionated radiotherapy for brainstem diffuse midline glioma.
    Tazhibi M; McQuillan N; Wei HJ; Gallitto M; Bendau E; Webster Carrion A; Berg X; Kokossis D; Zhang X; Zhang Z; Jan CI; Mintz A; Gartrell RD; Syed HR; Fonseca A; Pavisic J; Szalontay L; Konofagou EE; Zacharoulis S; Wu CC
    J Transl Med; 2024 Mar; 22(1):320. PubMed ID: 38555449
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Glioblastoma Therapy: Past, Present and Future.
    Obrador E; Moreno-Murciano P; Oriol-Caballo M; López-Blanch R; Pineda B; Gutiérrez-Arroyo JL; Loras A; Gonzalez-Bonet LG; Martinez-Cadenas C; Estrela JM; Marqués-Torrejón MÁ
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473776
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. CDKN2A promoter methylation enhances self-renewal of glioblastoma stem cells and confers resistance to carmustine.
    Wang J; Xi YF; Zhao Q; Guo JH; Zhang Z; Zhang MB; Chang J; Wu YQ; Su W
    Mol Biol Rep; 2024 Mar; 51(1):385. PubMed ID: 38438773
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Naringenin Induces cellular Apoptosis in Melanoma cells
    Fernando PDSM; Zhen AX; Piao MJ; Herath HMUL; Kang KA; Yoon SP; Boo HJ; Hyun CL; Hyun JW
    Anticancer Res; 2024 Mar; 44(3):1079-1086. PubMed ID: 38423648
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Genotoxic and Cytotoxic Activity of Fisetin on Glioblastoma cells.
    Beltzig L; Christmann M; Dobreanu M; Kaina B
    Anticancer Res; 2024 Mar; 44(3):901-910. PubMed ID: 38423634
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. METTL14-Mediated m6a Modification of CDKN2A Promotes the Development of Retinoblastoma by Inhibiting the p53 Pathway.
    Chen J; Zeng B
    Crit Rev Immunol; 2024; 44(3):89-98. PubMed ID: 38421707
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Genetic and epigenetic features of neuroendocrine prostate cancer and their emerging applications.
    Zhang X; Barnett E; Smith J; Wilkinson E; Subramaniam RM; Zarrabi A; Rodger EJ; Chatterjee A
    Int Rev Cell Mol Biol; 2024; 383():41-66. PubMed ID: 38359970
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Aberrant ATM signaling and homology-directed DNA repair as a vulnerability of p53-mutant GBM to AZD1390-mediated radiosensitization.
    Chen J; Laverty DJ; Talele S; Bale A; Carlson BL; Porath KA; Bakken KK; Burgenske DM; Decker PA; Vaubel RA; Eckel-Passow JE; Bhargava R; Lou Z; Hamerlik P; Harley B; Elmquist WF; Nagel ZD; Gupta SK; Sarkaria JN
    Sci Transl Med; 2024 Feb; 16(734):eadj5962. PubMed ID: 38354228
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Comparative assessment of direct and indirect cold atmospheric plasma effects, based on helium and argon, on human glioblastoma: an in vitro and in vivo study.
    Bakhtiyari-Ramezani M; Nohekhan M; Akbari ME; Abbasvandi F; Bayat M; Akbari A; Nasiri M
    Sci Rep; 2024 Feb; 14(1):3578. PubMed ID: 38347045
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Lamivudine, Doravirine, and Cabotegravir Downregulate the Expression of Human Endogenous Retroviruses (HERVs), Inhibit cell Growth, and Reduce Invasive Capability in Melanoma cell Lines.
    Zanrè V; Bellinato F; Cardile A; Passarini C; Monticelli J; Di Bella S; Menegazzi M
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338893
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Development of Chromosome 1q+ Specific treatment for Highest Risk Pediatric Posterior Fossa Ependymoma.
    Griesinger AM; Calzadilla AJ; Grimaldo E; Donson AM; Amani V; Pierce AM; Steiner J; Kargar S; Serkova NJ; Bertrand KC; Wright KD; Vibhakar R; Hankinson T; Handler M; Lindsay HB; Foreman NK; Dorris K
    Clin Cancer Res; 2024 Apr; 30(8):1544-1554. PubMed ID: 38334950
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Transformation of G1-G2 neuroendocrine tumors to neuroendocrine carcinomas following peptide receptor radionuclide therapy.
    Cordero-Hernandez IS; Ross AC; Dasari A; Halperin DM; Chasen B; Yao JC
    Endocr Relat Cancer; 2024 Apr; 31(4):. PubMed ID: 38329269
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Rise of oligodendroglioma hypermutator phenotype from a subclone harboring tp53 mutation after TMZ treatment.
    Higuchi F; Uzuka T; Matsuda H; Sumi T; Iwata K; Namatame T; Shin M; Akutsu H; Ueki K
    Brain Tumor Pathol; 2024 Apr; 41(2):80-84. PubMed ID: 38294664
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Expression of molecular markers and synergistic anticancer effects of chemotherapy with antimicrobial peptides on glioblastoma cells.
    Chernov AN; Kim AV; Skliar SS; Fedorov EV; Tsapieva AN; Filatenkova TA; Chutko AL; Matsko MV; Galimova ES; Shamova OV
    Cancer Chemother Pharmacol; 2024 May; 93(5):455-469. PubMed ID: 38280033
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Inhibition of Autophagy Aggravates
    Tsai CH; Huang HC; Lin KJ; Liu JM; Chen GL; Yeh YH; Lu TL; Lin HW; Lu MT; Chu PC
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279345
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. GlioPredictor: a deep learning model for identification of high-risk adult IDH-mutant glioma towards adjuvant treatment planning.
    Zheng S; Rammohan N; Sita T; Teo PT; Wu Y; Lesniak M; Sachdev S; Thomas TO
    Sci Rep; 2024 Jan; 14(1):2126. PubMed ID: 38267516
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 109.